2025
Machine learning validation of the AVAS classification compared to ultrasound mapping in a multicentre study
LAWRIE, Katerina; Petr WALDAUF; Peter BALAZ; Radosalv BORTEL; Ricardo LACERDA et. al.Basic information
Original name
Machine learning validation of the AVAS classification compared to ultrasound mapping in a multicentre study
Authors
LAWRIE, Katerina; Petr WALDAUF; Peter BALAZ; Radosalv BORTEL; Ricardo LACERDA; Emma AITKEN; Krzysztof LETACHOWICZ; Mario D’ORIA; Vittorio DI MASO; Pavel STASKO; Antonio GOMES; Joana FONTAINHAS; Matej PEKAŘ (703 Slovakia, belonging to the institution); Alena SRDELIC; Study Group VAVASC and Stephen O’NEILL
Edition
SCIENTIFIC REPORTS, BERLIN, NATURE PORTFOLIO, 2025, 2045-2322
Other information
Language
English
Type of outcome
Article in a journal
Field of Study
30212 Surgery
Country of publisher
Germany
Confidentiality degree
is not subject to a state or trade secret
References:
Impact factor
Impact factor: 3.900 in 2024
Organization unit
Faculty of Medicine
UT WoS
001401998100028
EID Scopus
999
Keywords in English
AVAS classification; machine learning validation; ultrasound mapping
Tags
International impact, Reviewed
Changed: 5/2/2025 09:30, Mgr. Tereza Miškechová
Abstract
In the original language
The Arteriovenous Access Stage (AVAS) classification simplifies information about suitability of vessels for vascular access (VA). It’s been previously validated in a clinical study. Here, AVAS performance was tested against multiple ultrasound mapping measurements using machine learning. A prospective multicentre international study (NCT04796558) with patient recruitment from March 2021-July 2024. Demographics, risk factors, vessels parameters, types of predicted and created VA (pVA, cVA) were collected. We modelled pVA and cVA using the Random Forest algorithm. Model performance was estimated and compared using Bayesian generalized linear models. ROC AUC with 95% credible intervals was the performance metric. 1151 patients were included. ROC AUC for pVA prediction by AVAS was 0.79 (0.77;0.82) and by mapping was 0.85 (0.83;0.88). ROC AUC for cVA prediction by AVAS was 0.71 (0.69;0.74) and by mapping was 0.8 (0.78;0.83). Using AVAS with other parameters increased the ROC AUC to 0.87 for pVA (0.84;0.89) and 0.82 (0.79;0.84) for cVA. Using mapping with other parameters increased the ROC AUC to 0.88 for pVA (0.86;0.91) and 0.85 (0.83;0.88) for cVA. Multiple mapping measurements showed higher performance at VA prediction than AVAS. However, AVAS is simpler and quicker, so may be preferable for routine clinical practice.